Literature DB >> 26822323

Monitoring of minimal residual disease in early T-cell precursor acute lymphoblastic leukaemia by next-generation sequencing.

Xiaoqing Pan1, Naoki Nariai1, Noriko Fukuhara2, Sakae Saito1, Yukuto Sato1, Fumiki Katsuoka1,3, Kaname Kojima1, Yoko Kuroki1, Inaho Danjoh1, Rumiko Saito1, Shin Hasegawa2, Yoko Okitsu2, Aiko Kondo2, Yasushi Onishi2, Fuji Nagami4, Hideyasu Kiyomoto5, Atsushi Hozawa6, Nobuo Fuse1, Masao Nagasaki1, Ritsuko Shimizu7, Jun Yasuda1, Hideo Harigae2, Masayuki Yamamoto1,3.   

Abstract

Entities:  

Keywords:  ETP-ALL; minimal residual disease; mutation detection; next generation sequencing; whole genome sequencing

Mesh：

Year:  2016        PMID： 26822323     DOI： 10.1111/bjh.13948

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

Authors:  Elias Jabbour; Nicholas J Short; Jeffrey L Jorgensen; Musa Yilmaz; Farhad Ravandi; Sa A Wang; Deborah A Thomas; Joseph Khoury; Richard E Champlin; Issa Khouri; Partow Kebriaei; Susan M O'Brien; Guillermo Garcia-Manero; Jorge E Cortes; Koji Sasaki; Courtney D Dinardo; Tapan M Kadia; Nitin Jain; Marina Konopleva; Rebecca Garris; Hagop M Kantarjian
Journal:  Cancer       Date:  2016-09-07       Impact factor: 6.860

Review 2.  Precision medicine in pediatric oncology: Lessons learned and next steps.

Authors:  Rajen J Mody; John R Prensner; Jessica Everett; D Williams Parsons; Arul M Chinnaiyan
Journal:  Pediatr Blood Cancer       Date:  2016-10-17       Impact factor: 3.167

3.  FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD).

Authors:  Luca Lo Nigro; Nellina Andriano; Barbara Buldini; Daniela Silvestri; Tiziana Villa; Franco Locatelli; Rosanna Parasole; Elena Barisone; Anna Maria Testi; Andrea Biondi; Maria Grazia Valsecchi; Carmelo Rizzari; Valentino Conter; Giuseppe Basso; Giovanni Cazzaniga
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.